Funding Received
$35 Million in 1 Round from 12 Investors
Most Recent Funding
$35 Million Series B on November 16, 2006
Headquarters:
Lincoln, RI
Description:
Neurotech is a biotechnology company developing sight-saving therapeutics for chronic retinal diseases.
Categories:
Biotechnology
Website:
http://www.neurotechusa.com

Company Details

Update

Neurotech is a privately held biotechnology company developing sight-saving therapeutics for chronic retinal diseases—including indications with significant unmet medical need that, as a whole, represent the largest market opportunity in ophthalmology.

Past Team (1)

Update

Board Members and Advisors (2)

Update

Investors (12)

Update

Offices/Locations (1)

Update
  • Office

    701 George Washington Highway

    Lincoln, RI 02865

    USA

Images (1)

Update
  • 58557824f0d7e1cf551beaf63405589f